Thomas Yip News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas yip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Yip Today - Breaking & Trending Today

DURECT Corporation (NASDAQ:DRRX) Q1 2024 Earnings Call Transcript

DURECT Corporation (NASDAQ:DRRX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Jamese Brown , Carl Byrnes , Jim Brown , Timothym Papp , Ed Arce , Francois Brisebois , Frank Brisebois , Thomas Yip , Tim Papp , Oppenheimer Co , Durect Corporation , Durect Corp , Corporation First Quarter , Call Transcript May , First Quarter , Chief Financial , Chief Financial Officer , Safe Harbor , Northland Capital ,

Iterum Therapeutics plc (NASDAQ:ITRM) Q1 2024 Earnings Call Transcript

Iterum Therapeutics plc (NASDAQ:ITRM) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Corey Fishman , Ed Arce , Michael Okunewitch , Louise Barrett , Coreyn Fishman , Thomas Yip , Judy Matthews , Judithm Matthews , Jason Mccarthy , Division Of Anti , Legal Affairs , Iterum Therapeutics Plc , Maxim Group , Iterum Therapeutics , Call Transcript May , Iterum Therapeutics First Quarter , Senior Vice President , Interim Therapeutic , Chief Executive Officer , Chief Financial Officer , Oral Sulopenem , Risk Factors , Quarterly Report , Oral Penem , Drug Evaluation , Thanks Thomas ,

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. ....

United States , Rob Shawah , Ed Arce , Kevin Garey , Michael Okunewitch , Dave Luci , David Luci , Thomas Yip , Robert Deluccia , Jason Mccarthy , Robert Shawah , Bob Deluccia , International Conference On Molecular Biology , Exchange Commission , European Medicines Agency , University Of Houston College Pharmacy , Maxim Group , Microbial Resistance Congress , Acurx Pharmaceuticals Third Quarter , Acurx Pharmaceuticals Inc , Acurx Pharmaceuticals , Call Transcript November , Chief Financial , Executive Chairman , World Anti Microbial Resistance Congress , Gram Positive Bacterial Infections ,

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2023 Earnings Call Transcript

Operator: Welcome to the AcelRx third quarter 2023 financial results conference call. ....

South Korea , Vince Angotti , Thomas Yip , Laurence Busse , David Boldt , Pam Palmer , James Molloy , Raffi Asadorian , Ed Arce , Emory University School Of Medicine , Exchange Commission , University Of Pittsburgh Medical Center , Department Of Defense Or Do , Department Of Defense , Acelrx Pharmaceuticals Inc , Alliance Global Partners , School Of Medicine , Alora Pharmaceuticals , Acelrx Pharmaceuticals , Call Transcript November , Acelrx Pharmaceutical Chief Financial , Chief Executive Officer , Chief Medical , Breakthrough Device Designation , Investigator Meeting , Nafamostat Efficacy ,

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q2 2023 Earnings Call Transcript

Operator: Welcome to the AcelRx Second Quarter 2023 Financial Results Conference Call. ....

South Korea , Pam Palmer , Thomas Yip , Raffi Asadorian , Vince Angotti , Ed Arce , University Of Pittsburgh Medical Center , Department Of Defense , Exchange Commission , Health Photo , Us Army , Acelrx Pharmaceuticals Inc , Department Of Defense Or Do , Alora Pharmaceuticals , Acelrx Pharmaceuticals , Call Transcript August , Acelrx Second Quarter , Results Conference , Acelrx Chief Financial , Chief Executive Officer , Chief Medical , Julia Zyablova , Pittsburgh Medical Center , Nantahala Capital Management , Performing Commodities , Ark Invest Stock Portfolio ,